U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell®

U.S. FDA Doubles Patient Numbers Permitted for Compassionate Use of ReCell®

The U.S. Food and Drug Administration (FDA) for the expansion of its Compassionate Use Investigational Device Exemption (IDE) program for ReCell®Read More

No Comments

Sorry, the comment form is closed at this time.